Video

Paul S. Carbone, MD: Risk Factors for Autism Spectrum Disorder

Author(s):

Children are now screened for autism at 18 and 24 months.

Identifying the maternal risk factors of autism spectrum disorder (ASD) could be beneficial for earlier screenings and treatment plans for patients.

In an interview with HCPLive®, Paul S. Carbone, MD, professor of pediatrics, University of Utah, explained some of the advancements in pediatric autism care that has occurred in recent years.

Adopting better screening methods and advancing treatment has been slow, but new evidence-based research is helping to improve care. For example, the majority of pediatricians autism screenings are now routine at the 18 and 24-month visits.

Carbone said in the last decade the knowledge on how to best manage and treat ASD has expanded and improved, based on a lot of new genetic discoveries about autism. There has also been advancements in learning exactly how autism unfolds in early years, which helps provide better treatment plans down the line.

And more regular screenings allows doctors to focus on the processes of care.

Another area of focus will be on co-occurring conditions, including gastrointestinal problems, sleep issues, and other psychiatric struggles, such as ADHD and stress.

Carbone will present 2 presentations during the 2021 American Academy of Pediatrics Virtual Conference that focus on autism beyond diagnosis, specifically on managing the disease.

Related Videos
Ladan Zand, MD: Evaluating Obinutuzumab in Primary FSGS and Further Research
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Kishore Iyer, MD , MBBS | Credit: Kishore Iyer on LinkedIn
Evan Dellon, MD, MPH | Credit: UNC Chapel Hill
Marlyn Mayo, MD | Credit: ACG
Kishore Iyer, MD, MBBS | Credit: Kishore Iyer on LinkedIn
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
Bruce Sands, MD | Credit: Alimentiv
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University
© 2024 MJH Life Sciences

All rights reserved.